BIND Therapeutics To Report First Quarter 2015 Financial Results On May 7, 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today announced it will host a conference call and live audio webcast on May 7, 2015, at 8:30 a.m. ET to report first quarter 2015 financial results.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.